Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Cystic Fibrosis: Management
Myocarditis IV: Nursing Management
Irritable Bowel Syndrome III: Medical and Nursing Management
Gastritis III: Clinical Manifestations and Management
Heart Failure V: Medical Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 26, 2026

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
S D Joustra1, C A Heinen1, N Schoenmakers1
1Department of Pediatrics (S.D.J., J.M.W., W.O.), Department of Medicine (S.D.J., N.R.B., A.M.P.), Division of Endocrinology, Department of Clinical Chemistry and Laboratory Medicine (B.E.P.B.), and Department of Clinical Genetics (M.L.), Leiden University Medical Center, 2300 C Leiden, The Netherlands; Department of Pediatric Endocrinology (C.A.H., A.S.P.v.T.), Emma Children's Hospital, and Department of Endocrinology and Metabolism (C.A.H., E.F.), Academic Medical Center, University of Amsterdam, 1100 DE, The Netherlands; University of Cambridge Metabolic Research Laboratories (N.S.), Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge DB2 2OO, United Kingdom; Division of Endocrine and Metabolic Disorders (M.B.), Instituto di Ricovero e Cura a Carettere Scientifico, Instituto Auxologica Italiano, 20132 Milan, Italy; Department of Clinical Sciences and Community Health (M.B., L.P.), Università degli Studi di Milano, 20122 Milan, Italy; Department of Pharmacology and Therapeutics (M.-O.T., D.J.B.), McGill University, Montréal, Québec, Canada H9X 3V9.
IGSF1 deficiency, the most common cause of central hypothyroidism, presents with varied endocrine issues in males and carriers. This study offers clinical management recommendations for IGSF1 mutations.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: